391 related articles for article (PubMed ID: 17041626)
21. 4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis.
Rojo F; Najera L; Lirola J; Jiménez J; Guzmán M; Sabadell MD; Baselga J; Ramon y Cajal S
Clin Cancer Res; 2007 Jan; 13(1):81-9. PubMed ID: 17200342
[TBL] [Abstract][Full Text] [Related]
22. mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer.
Dann SG; Selvaraj A; Thomas G
Trends Mol Med; 2007 Jun; 13(6):252-9. PubMed ID: 17452018
[TBL] [Abstract][Full Text] [Related]
23. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
[TBL] [Abstract][Full Text] [Related]
24. Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy.
Zhang HY; Zhang PN; Sun H
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):81-6. PubMed ID: 19540648
[TBL] [Abstract][Full Text] [Related]
25. mTOR signaling and the molecular adaptation to resistance exercise.
Bodine SC
Med Sci Sports Exerc; 2006 Nov; 38(11):1950-7. PubMed ID: 17095929
[TBL] [Abstract][Full Text] [Related]
26. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.
Serra V; Markman B; Scaltriti M; Eichhorn PJ; Valero V; Guzman M; Botero ML; Llonch E; Atzori F; Di Cosimo S; Maira M; Garcia-Echeverria C; Parra JL; Arribas J; Baselga J
Cancer Res; 2008 Oct; 68(19):8022-30. PubMed ID: 18829560
[TBL] [Abstract][Full Text] [Related]
27. TNF-alpha increases protein content in C2C12 and primary myotubes by enhancing protein translation via the TNF-R1, PI3K, and MEK.
Plaisance I; Morandi C; Murigande C; Brink M
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E241-50. PubMed ID: 17971516
[TBL] [Abstract][Full Text] [Related]
28. The ubiquitination of ribosomal S6 kinases is independent from the mitogen-induced phosphorylation/activation of the kinase.
Gwalter J; Wang ML; Gout I
Int J Biochem Cell Biol; 2009 Apr; 41(4):828-33. PubMed ID: 18786649
[TBL] [Abstract][Full Text] [Related]
29. A role for Akt in epidermal growth factor-stimulated cell cycle progression in cultured hepatocytes: generation of a hyperproliferative window after adenoviral expression of constitutively active Akt.
Luo Y; Dixon CJ; Hall JF; White PJ; Boarder MR
J Pharmacol Exp Ther; 2007 Jun; 321(3):884-91. PubMed ID: 17371807
[TBL] [Abstract][Full Text] [Related]
30. Expanding mTOR signaling.
Yang Q; Guan KL
Cell Res; 2007 Aug; 17(8):666-81. PubMed ID: 17680028
[TBL] [Abstract][Full Text] [Related]
31. The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth.
Yang X; Yang C; Farberman A; Rideout TC; de Lange CF; France J; Fan MZ
J Anim Sci; 2008 Apr; 86(14 Suppl):E36-50. PubMed ID: 17998426
[TBL] [Abstract][Full Text] [Related]
32. PI3K, RSK, and mTOR signal networks for the GST gene regulation.
Kim SG; Lee SJ
Toxicol Sci; 2007 Apr; 96(2):206-13. PubMed ID: 17122411
[TBL] [Abstract][Full Text] [Related]
33. Carcinoma-associated eIF3i overexpression facilitates mTOR-dependent growth transformation.
Ahlemann M; Zeidler R; Lang S; Mack B; Münz M; Gires O
Mol Carcinog; 2006 Dec; 45(12):957-67. PubMed ID: 16929481
[TBL] [Abstract][Full Text] [Related]
34. The phosphoinositide 3-kinase pathway and cancer.
Stokoe D
Expert Rev Mol Med; 2005 Jun; 7(10):1-22. PubMed ID: 15938760
[TBL] [Abstract][Full Text] [Related]
35. mRNA translation: unexplored territory in renal science.
Kasinath BS; Mariappan MM; Sataranatarajan K; Lee MJ; Feliers D
J Am Soc Nephrol; 2006 Dec; 17(12):3281-92. PubMed ID: 16959824
[TBL] [Abstract][Full Text] [Related]
36. Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer.
Dong Z; Zhang JT
Crit Rev Oncol Hematol; 2006 Sep; 59(3):169-80. PubMed ID: 16829125
[TBL] [Abstract][Full Text] [Related]
37. Cell signaling in protein synthesis ribosome biogenesis and translation initiation and elongation.
Mahoney SJ; Dempsey JM; Blenis J
Prog Mol Biol Transl Sci; 2009; 90():53-107. PubMed ID: 20374739
[TBL] [Abstract][Full Text] [Related]
38. A translation control reporter system (TCRS) for the analysis of translationally controlled processes in the vertebrate cell.
Wiesenthal V; Leutz A; Calkhoven CF
Nucleic Acids Res; 2006 Feb; 34(3):e23. PubMed ID: 16473846
[TBL] [Abstract][Full Text] [Related]
39. [When translation arises from its TORpor].
Le Bacquer O; Martineau Y; Mamane Y
Med Sci (Paris); 2006 May; 22(5):514-8. PubMed ID: 16687120
[TBL] [Abstract][Full Text] [Related]
40. Teaching resources. Regulation of protein translation.
Landau EM
Sci STKE; 2006 Mar; 2006(325):tr3. PubMed ID: 16522872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
